nVerses Capital’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,500
Closed -$258K 209
2024
Q3
$258K Buy
+5,500
New +$258K 0.12% 273